News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025
News Daily News More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin L.A. McKeown February 14, 2025
News Conference News ISC 2025 Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 11, 2025
News Conference News STS 2025 Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival Yael L. Maxwell January 27, 2025
News Daily News Aspirin Use for Primary Prevention Declining in US: NHANES Michael O'Riordan January 24, 2025
News Industry News Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States January 21, 2025
News Daily News Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist Todd Neale January 15, 2025
News Daily News Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain Yael L. Maxwell January 13, 2025
News Daily News Just One in Five Grand Rounds Lectures Given by Women Michael O'Riordan January 07, 2025
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023